Recombinant epidermal growth factor gel (Pavay Gene Pharmaceutical)

重组人表皮生长因子凝胶(桂林华诺威基因药业)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant epidermal growth factor gel (Pavay Gene Pharmaceutical)
Drug Alias Name重组人表皮生长因子凝胶(酵母)易孚
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsBurnsSkin Ulcer
Global Approved IndicationsBurnsSkin Ulcer
Approved Indications in ChinaBurnsSkin Ulcer
Original Approved Country/TerritoryMainland China
Original Approved Date2002/12/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsBurnsSkin Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A